WHO WE ARE
ABOUT POLYGON™ MEDICAL
Polygon Medical, Inc, is a privately held company based in Boston, MA, that has developed a cost effective, simple, easy to use device for the removal of small intrauterine polyps. The Polygon Tissue Resection device is FDA cleared and utilizes an ergonomic handle for control of the tissue cutting mechanism. Since the cutting bay is normally closed, fluid loss is minimized making it possible to complete procedures with only a pressure cuff and fluid bag for fluid distension.
Polygon Medical was formed by a team of forward-thinking doctors and seasoned medical device executives to respond to the increasing need for a simple, safe and effective means for removing small polyps in the comfort of the office setting or an ASC or OR.
THE MESSAGE WAS CLEAR
Doctors were seeking a simple, cost-effective alternative that enabled them to see and treat small pathology.
They wanted an easy to use, more efficient, standardized device to support their desire:
To be able to remove the small polyps that are so
frequently observed with hysteroscopy in the office.Approach must be low risk and be financially attractive for both patient and physician.
Current methods requiring OR appointments, set-up and time away from the office for both patient and physician are a barrier to rapid treatment. The Polygon Resection device was created to enable the clinician to conduct diagnostic hysteroscopy, remove small polyps and take visually guided biopsies without the need for a complicated fluid management system.
THE POLYGON™ TEAM
Ron Adams,
Chief Technology Officer
Mr. Adams has led Polygon Medical through its development, FDA Clearance and commercial launch. He has spent 30 years commercializing innovative medical devices and procedures and has a track record of building and directing world-class teams and organizations. He launched the first powered hysteroscopic morcellator system with Smith & Nephew (IUR System aka TruClear). He served as Co-Founder and Chief Technology Officer at Interlace Medical (Myosure). Previously he has held senior R&D leadership roles at Boston Scientific, Smith & Nephew and Ethicon Endosurgery. Mr. Adams is a listed inventor on over 70 US and International patents.
Jim Greenberg, MD,
Chief Medical Officer
Dr. Greenberg is a practicing obstetrician/gynecologist in the Boston area and serves on the faculty at Harvard Medical School. He is actively engaged in clinical research as a physician-scientist and coauthored over 100 publications, abstracts and videos. He is currently the Chief of Gynecology at the Brigham & Women’s Faulkner Hospital and a Vice Chairman of Obstetrics & Gynecology at Brigham & Women’s Hospital. He was the lead medical consultant at Interlace Medical which was acquired by Hologic in 2011. In addition, he has served as a medical device consultant for multiple companies including Ethicon Endosurgery, Hologic, Smith & Nephew, Channel MedSystems and others.
Have a question?
Ready to schedule a demo?
Please use the contact information and form to ask general questions and to schedule a demo.
PHONE